空间管理您的位置: 分析测试百科网 » 糖及糖类标准品,磷脂,脂肪酸,花青素 » 博客

上海惠诚生物专业提供糖类产品及糖类标准品，脂肪酸标准品，花青素标准品，类胡萝卜素,人乳寡糖等食品分析标准品。联系电话：17715331663 QQ：2303607288

158021-47-7 a-半乳糖神经酰胺KRN7000上海惠诚生物

上一篇 / 下一篇 2020-08-06 11:22:42/ 个人分类：糖化学

查看( 513 ) / 评论( 0 ) / 评分( 0 / 0 )

货号：KRN7000

化学品名：α-半乳糖神经酰胺 α-Galactosylceramide (KRN7000)

CAS号：158021-47-7

类别：Amino Acids & Derivatives, Protein Kinase Inhibitors and Activators

分子式：C50H99NO9

分子量：858.32

规格1：0.25mg

外观：White Solid

纯度：≥96% (NMR)

别名：2S,3S,4R)-1-O-(α-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol

α-GalCer

α-Gal-Cer

KRN7000

alpha-galactosyl ceramide

溶解性：Soluble in pyridine. Solubilization in Tween20 or PBS for cell culture use see online protocol.

α-半乳糖神经酰胺的英文为α-Galactosylceramide，上海惠诚生物提供纯度≥95%的α-半乳糖神经酰胺，规格 1mg或者5mg，大包装请单独咨询。α-半乳糖神经酰胺别称KRN7000。更多请联系我们17715331663 QQ：2303607288

Product Description

Synthetic. Originally isolated from the marine sponge Angelas mauritianus [1].
Immunostimulant [1, 2, 3].
Potent stimulator of natural killer T (NKT) cells [4, 5].
Specific ligand of the lipid-binding MHC class I-like protein CD1d in human and mouse NKT cells [5].
Protects against LPS-induced shock [7].
Potent antitumor compound [2, 6, 8].

Product References

Synthesis of alpha-, beta-monoglycosylceramides and four diastereomers of an alpha-galactosylceramide: M. Morita, et al.; Bioorg. Med. Chem. Lett. 5, 699 (1995)
Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties: K. Motoki, et al.; Biol. Pharm. Bull. 18, 1487 (1995)
Immunostimulatory activities of monoglycosylated alpha-D-pyranosylceramides: A. Uchimura, et al.; Bioorg. Med. Chem. 5, 2245 (1997)
Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein: Fujii S, et al.; J. Exp. Med. 198, 267 (2003)
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides: K.O. Yu, et al.; PNAS 102, 3383 (2005)
A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer: A. Ishikawa, et al.; Clin. Cancer Res. 11, 1910 (2005)
Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock: G. Sireci, et al.; J. Leukoc. Biol. 81, 607 (2007)
α-Galactosylceramide activates antitumor immunity against liver tumor: T. Tatsumi, et al.; Hepatol. Res. 41, 160 (2011)

α-Galactosylceramide was originally isolated from an extract of the Okinawan marine sponge Agelas mauritianus. α-Galactosylceramide is a specific ligand for human and mouse natural killer T (NKT) cells and exhibits potent anti-tumor activity with murine in vivoexperiments including subcutaneous implanted model and metastatic models in the liver and lung. In the liver metastatic models, treatment with α-galactosylceramide suppressed the growth of tumors and prolonged the survival term of the tumor-bearing mice. α-Galactosylceramide has been reported to show various immunological effects in infectious diseases, autoimmune disease and graft versus host disease in mice.1

Chemically synthesized. Provided with a BSE/TSE statement.

Purity by HPLC-CAD – example chromatogram on the right.